Journal article

Effectiveness of Rabbit Antithymocyte Globulin in Chronic Lung Allograft Dysfunction

S Izhakian, WG Wasser, BD Fox, B Vainshelboim, JE Reznik, MR Kramer

Transplantation Proceedings | ELSEVIER SCIENCE INC | Published : 2016


BACKGROUND: Rabbit antithymocyte globulin (rATG) therapy has been shown to be beneficial in lung transplant recipients as induction therapy for treating acute lung rejection; however, its role in chronic lung rejection has been reported only rarely. We evaluated the effectiveness of rATG therapy in slowing the progression of chronic lung allograft dysfunction (CLAD) syndrome. METHODS: We conducted a retrospective review of 25 lung transplant patients with CLAD who received rATG therapy in the Pulmonary Institute of Rabin Medical Center, Israel, between May 2005 and February 2016. Response to treatment was divided into 2 categories: stabilization, defined as a halting of the decline of forced..

View full abstract